These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11423858

  • 1. Clearance in psoriasis treatment.
    Kumar B, Saraswat A.
    J Am Acad Dermatol; 2001 Jul; 45(1):153-4. PubMed ID: 11423858
    [No Abstract] [Full Text] [Related]

  • 2. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M.
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract] [Full Text] [Related]

  • 3. Intermittent, short term use of methotrexate for exacerbations of psoriasis.
    Clark AR, Feldman SR.
    Int J Dermatol; 1997 Dec; 36(12):954-5. PubMed ID: 9466209
    [No Abstract] [Full Text] [Related]

  • 4. Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series.
    Gisondi P, Mattiucci A, Tonin B, Girolomoni G.
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):e246-e247. PubMed ID: 30801786
    [No Abstract] [Full Text] [Related]

  • 5. Methotrexate and psoriasis in the era of new biologic agents.
    Saporito FC, Menter MA.
    J Am Acad Dermatol; 2004 Feb; 50(2):301-9. PubMed ID: 14726893
    [No Abstract] [Full Text] [Related]

  • 6. The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate.
    Choi CW, Kim BR, Seo E, Youn SW.
    Br J Dermatol; 2017 Dec; 177(6):1740-1741. PubMed ID: 28129675
    [No Abstract] [Full Text] [Related]

  • 7. Methotrexate-betamethasone weekly oral pulse in psoriasis.
    Gupta R, Gupta S.
    J Dermatolog Treat; 2007 Dec; 18(5):291-4. PubMed ID: 17852636
    [Abstract] [Full Text] [Related]

  • 8. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
    Gisondi P, Giglio MD, Girolomoni G.
    J Dermatolog Treat; 2006 Dec; 17(3):172-5. PubMed ID: 16854760
    [Abstract] [Full Text] [Related]

  • 9. Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate.
    Stanford CW, Kollipara R, Melookaran AM, Hall JC.
    Cutis; 2014 Sep; 94(3):153-5. PubMed ID: 25279477
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate in psoriasis: consensus conference.
    Roenigk HH, Auerbach R, Maibach H, Weinstein G, Lebwohl M.
    J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
    [No Abstract] [Full Text] [Related]

  • 11. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
    Ranjan N, Sharma NL, Shanker V, Mahajan VK, Tegta GR.
    J Dermatolog Treat; 2007 Mar; 18(5):295-300. PubMed ID: 17852635
    [Abstract] [Full Text] [Related]

  • 12. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
    Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS, Psoriasis Investigator Group (PsIG) of the Pediatric Dermatology Research Alliance and the European Working Group on Pediatric Psoriasis (EWGPP).
    JAMA Dermatol; 2017 Nov 01; 153(11):1147-1157. PubMed ID: 28903160
    [Abstract] [Full Text] [Related]

  • 13. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M, Ali S.
    J Am Acad Dermatol; 2001 Nov 01; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [Abstract] [Full Text] [Related]

  • 14. [Eventration and methotrexate in psoriasis].
    Schmutz JL, Barbaud A, Trechot P.
    Ann Dermatol Venereol; 2010 Oct 01; 137(10):672. PubMed ID: 20932456
    [No Abstract] [Full Text] [Related]

  • 15. A study of the use of drugs in patients suffering from psoriasis and their impact on quality of life.
    Karamata VV, Gandhi AM, Patel PP, Sutaria A, Desai MK.
    Indian J Pharmacol; 2017 Oct 01; 49(1):84-88. PubMed ID: 28458428
    [Abstract] [Full Text] [Related]

  • 16. Topical psoriasis therapies and unmet patient needs: the importance of optimizing methotrexate.
    Greenberg R.
    Cutis; 2016 Jan 01; 97(1):55-6. PubMed ID: 26919356
    [No Abstract] [Full Text] [Related]

  • 17. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan 01; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 18. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
    Skrabl-Baumgartner A, Weger W, Salmhofer W, Jahnel J.
    Pediatr Dermatol; 2015 Jan 01; 32(1):e13-4. PubMed ID: 25644044
    [Abstract] [Full Text] [Related]

  • 19. Juvenile generalized pustular psoriasis.
    Kalla G, Goyal AM.
    Pediatr Dermatol; 1996 Jan 01; 13(1):45-6. PubMed ID: 8919525
    [Abstract] [Full Text] [Related]

  • 20. Combined use of systemic agents for psoriasis: a systematic review.
    Busard C, Zweegers J, Limpens J, Langendam M, Spuls PI.
    JAMA Dermatol; 2014 Nov 01; 150(11):1213-20. PubMed ID: 25188393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.